Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease - Wilke, Carlo; Santos, Marcia Cristina Teixeira; Schulte, Claudia; Deuschle, Christian; Scheller, Dieter; Verbelen, Moira; Brockmann, Kathrin; Thaler, Anna‐Katharina; Sünkel, Ulrike; Roeben, Benjamin; Bujac, Sarah; Metzger, Florian G.; et al. (Movement disorders, 2020)
Keywords: biomarker; Biomarkers; Blood levels; Humans; Intermediate Filaments; Longitudinal studies; longitudinal study; Movement disorders; Neurodegenerative diseases; neurofilament light chain (NfL); Neurofilament Proteins; Parkinson Disease; Parkinson's disease; Parkinson's disease (PD); Precision medicine; premanifest disease; Prodromal Symptoms; serum; single molecule array (Simoa) technique; single molecule array (Simoa) technique; neurofilament light chain (NfL); Parkinson's disease (PD); prodromal symptoms; premanifest disease; longitudinal study; biomarker; serum